These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9021238)

  • 1. Increased plasma guanylin levels in patients with impaired renal function.
    Kinoshita H; Nakazato M; Yamaguchi H; Matsukura S; Fujimoto S; Eto T
    Clin Nephrol; 1997 Jan; 47(1):28-32. PubMed ID: 9021238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency.
    Nakazato M; Yamaguchi H; Shiomi K; Date Y; Fujimoto S; Kangawa K; Matsuo H; Matsukura S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1966-75. PubMed ID: 7811289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal electrolyte effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylin and related peptides.
    Bełtowski J
    J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.
    Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
    Clin Nephrol; 1987 Feb; 27(2):84-6. PubMed ID: 2951044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency.
    Nakazato M; Yamaguchi H; Kinoshita H; Kangawa K; Matsuo H; Chino N; Matsukura S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):586-93. PubMed ID: 8607808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration of human adrenomedullin in patients on hemodialysis.
    Washimine H; Yamamoto Y; Kitamura K; Tanaka M; Ichiki Y; Kangawa K; Matsuo H; Eto T
    Clin Nephrol; 1995 Dec; 44(6):389-93. PubMed ID: 8719551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and plasma concentration of human guanylin.
    Date Y; Nakazato M; Yamaguchi H; Miyazato M; Matsukura S
    Intern Med; 1996 Mar; 35(3):171-5. PubMed ID: 8785447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
    Forte LR
    Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intestinal guanylin system and seawater adaptation in eels.
    Takei Y; Yuge S
    Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of uroguanylin in patients on maintenance dialysis therapy.
    Fukae H; Kinoshita H; Fujimoto S; Nakazato M; Eto T
    Nephron; 2000 Mar; 84(3):206-10. PubMed ID: 10720889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
    Abe M; Kaizu K; Matsumoto K
    Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel rat guanylin molecules, guanylin-94 and guanylin-16, do not increase cyclic GMP production in T84 cells.
    Yamaguchi H; Nakazato M; Miyazato M; Kangawa K; Matsuo H; Matsukura S
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1204-10. PubMed ID: 7575531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The changes of guanylin in plasma and lung tissue from asthmatic guinea pigs].
    Chen Y; Zhao M; Pang B
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):410-2. PubMed ID: 11778506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanylyl cyclase receptors and guanylin-like peptides in reptilian intestine.
    Krause WJ; Freeman RH; Eber SL; Hamra FK; Currie MG; Forte LR
    Gen Comp Endocrinol; 1997 Aug; 107(2):229-39. PubMed ID: 9245531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.
    Forte LR; Fan X; Hamra FK
    Am J Kidney Dis; 1996 Aug; 28(2):296-304. PubMed ID: 8768930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.
    Eisenhauer T; Talartschik J; Scheler F
    Klin Wochenschr; 1986; 64 Suppl 6():68-72. PubMed ID: 2948067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.